NCT02996526

Brief Summary

Population-based single centre, blinded, prospective cohort study of the impact of recurrent laryngeal nerve (RLN) injury on Thoracic Surgery patients. The principal outcome of interest is the effect of RLN injury on respiratory complications. Voice, swallowing, cardiac and mortality outcomes will also be determined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2016

Completed
13 days until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 19, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2018

Completed
Last Updated

January 31, 2020

Status Verified

January 1, 2020

Enrollment Period

1.4 years

First QC Date

August 19, 2016

Last Update Submit

January 29, 2020

Conditions

Keywords

vocal cord palsy dysfunction thoracic surgery complication

Outcome Measures

Primary Outcomes (1)

  • Number of patients with vocal cord dysfunction assessed by nasolaryngoscopy on the first post-operative day

    Post-operative day 1

Secondary Outcomes (6)

  • Number of patients with respiratory complictions

    Within 30 days of operation

  • Number of patients with vocal cord dysfunction assessed by nasolaryngoscopy prior to operation

    Day of operation

  • Hospital length of stay

    From date of primary operation to discharge

  • The number of patients with swallowing difficulties, cardiac complications and who have died

    From the date of operation to day 30 after operation

  • ICU length of stay

    From date of operation to discharge from hospital

  • +1 more secondary outcomes

Study Arms (2)

Intact Vocal Cord Mobility

Patients with normal laryngeal function post thoracic surgery

Vocal Cord Dysfunction

Patients with abnormal vocal cord movement of 1 or both vocal cords post thoracic surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing thoracic surgery at Health Sciences Centre in Winnipeg, Canada. This is a tertiary care centre with a population-based referral base of 1.5 million people.

You may qualify if:

  • All patients undergoing thoracic surgery at Health Sciences Centre Winnipeg. Recruitment will be performed by the thoracic surgeon faculty within the Division of Thoracic Surgery. Written informed consent will be obtained from the patient by an independent research assistant.
  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Provide signed and dated informed consent form.
  • Willing to comply with all study procedures and be available for the duration of the study.
  • Male or female, aged 18 and over..
  • Have a condition requiring surgical entry into the thoracic cavity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Sciences Centre

Winnipeg, Manitoba, R3A1R9, Canada

Location

MeSH Terms

Conditions

Vocal Cord Paralysis

Condition Hierarchy (Ancestors)

Laryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesVagus Nerve DiseasesCranial Nerve DiseasesNervous System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sadeesh Srinathan, MD

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Sadeesh Srinathan Associate Professor Section of Thoracic Surgery

Study Record Dates

First Submitted

August 19, 2016

First Posted

December 19, 2016

Study Start

September 1, 2016

Primary Completion

January 31, 2018

Study Completion

April 7, 2018

Last Updated

January 31, 2020

Record last verified: 2020-01

Locations